This site is intended for healthcare professionals
  • Home
  • /
  • News & Insights
  • /
  • News trends
  • /
  • Microbiome
  • /
  • Dysbiosis and Clostridioides difficile: Managing t...
News

Dysbiosis and Clostridioides difficile: Managing the burden of disease

Read time: 9 mins
Last updated:15th Jan 2021
Published:30th Nov 2020
Developed by EPG Health for Medthority in collaboration with Ferring. This content is intended for healthcare professionals only, and it has been funded and reviewed by Ferring for scientific accuracy.

Clostridioides difficile (C. diff) is the most common hospital-acquired gastrointestinal (GI) infection. 

C. diff infection (CDI) recurs in up to 50% of cases1 and is associated with a one month mortality rate of more than 10%2

Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest

Developed by EPG Health for Medthority in collaboration with Ferring. This content is intended for healthcare professionals only, and it has been funded and reviewed by Ferring for scientific accuracy.